Arcturus Therapeutics
![arcturus therapeutics, sa-mrna, covid-19, vaccine, booster, immune response, phase 1/2 trial](https://pharmtales.com/wp-content/uploads/2023/09/Arcturus-reports-positive-results-for-sa-mRNA-COVID-boosters-in-phase-1_2-trial.jpg)
Arcturus reports positive results for sa-mRNA COVID boosters in phase 1/2 trial
Anika Sharma
Amid a shrinking COVID-19 vaccine market, Arcturus Therapeutics is forging ahead with its mRNA candidate, revealing promising early data demonstrating ...
![Japan Invests $115M in Arcturus’ mRNA Manufacturing Joint Venture](https://pharmtales.com/wp-content/uploads/2023/08/Japanese-Government-Backs-Arcalis-with-115-Million-Grants-for-mRNA-Vaccine-Production.jpg)
Japanese Government Backs Arcalis with $115 Million Grants for mRNA Vaccine Production
SG Tylor
Following Daiichi Sankyo’s recent accomplishment of securing Japan’s first mRNA vaccine approval, a potential competitor has emerged backed by significant ...